Vulnerable plaque intervention: State of the art

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 3, 2008, Pages 367-374

  Young, John J ^a   Phillips, Harry R ^b   Marso, Steven P ^c   Granada, Juan F ^d   McPherson, John A ^e   Waksman, Ron ^f   Steinhubl, Steven R ^g   Schwartz, Robert S ^h   Stone, Gregg W ⁱ  

^a Swedish Heart and Vascular Institute   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Mid America Heart Institute   (United States)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f WASHINGTON HOSPITAL CENTER   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

ⁱ NewYork Presbyterian Hospital   (United States)

Author keywords

Coronary intervention; Invasive imaging; Natural history; Noninvasive imaging; Risk assessment; Vulnerable plaque

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INTRAVASCULAR ULTRASOUND; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; RESTENOSIS; REVIEW; RISK ASSESSMENT; THERMOGRAPHY; THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHEROSCLEROSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; FEMALE; HEART CATHETERIZATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPECTRUM ANALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 41149097184     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21354     Document Type: Review

References (50)

1. Smith SC, Jr, Feldman TE, Hirshfeld JW, Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). J Am Coll Cardiol 2006;47: e1-e121.
2. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
3. Cutlip DE, Chhabra AG, Baim DS, et al. Beyond restenosis: Five-year clinical outcomes from second-generation coronary stent trials. Circulation 2004;110:1226-1230.
4. Glaser R, Selzer F, Faxon DP, et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 2005;111:143-149.
5. Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999;34:1348-1359.
6. Smith SC, Jr, Greenland P, Grundy SM. AHA conference proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Executive summary. American Heart Association. Circulation 2000;101:111-116.
7. Grundy SM, Bazzarre T, Cleeman J, et al. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Medical office assessment: Writing Group I. Circulation 2000;101:E3-E11.
8. Smith SC, Jr, Amsterdam E, Balady GJ, et al. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Tests for silent and inducible ischemia: Writing Group II. Circulation 2000;101:E12-E16.
9. Greenland P, Abrams J, Aurigemma GP, et al. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000;101:E16-E22.
10. Smith SC, Jr, Blair SN, Bonow RO, et al. AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 2001;104:1577-1579.
11. Smith SC, Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113: 2363-2372.
12. LaBresh KA, Ellrodt AG, Gliklich R, et al. Get with the guidelines for cardiovascular secondary prevention: Pilot results. Arch Intern Med 2004;164:203-209.
13. PROSPECT trial: An imaging study in patients with unstable atherosclerotic lesions. www.clinicaltrials.gov (Last accessed September 2006).
14. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-250, 310-318.
15. Ambrose JA, Winters SL, Arora RR, et al. Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol 1986;3:472-478.
16. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000;343:915-922.
17. Hong MK, Mintz GS, Lee CW, et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: A three-vessel intravascular ultrasound study in 235 patients. Circulation 2004;110:928-933.
18. Kotani JI, Mintz GS, Castagna MT, et al. Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation 2003;107:2889-2893.
19. Qiao JH, Fishbein MC. The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis. J Am Coll Cardiol 1991;17:1138-1142.
20. Maehara A, Mintz GS, Bui AB, et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 2002;40:904-910.
21. von Birgelen C, Klinkhart W, Mintz GS, et al. Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: An intravascular ultrasound study in vivo. J Am Coll Cardiol 2001;37:1864-1870.
22. Fujii K, Mintz GS, Carlier SG, et al. Intravascular ultrasound profile analysis or ruptured coronary plaques. Am J Cardiol 2006; 98:429-435.
23. Wang JC, Normand SL, Mauri L, Kuntz RE. Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation 2004;110:278-284.
24. Schaar JA, Muller JE, Falk E, et al. Terminology for high-risk and vulnerable coronary artery plaque. Report of a meeting on the vulnerable plaque, June 17-18, 2003, Santorini, Greece. Eur Heart J 2004;25:1077-1082.
25. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient. A call for new definitions and risk assessment strategies, Part I. Circulation 2003;108:1664-1672.
26. Naghhavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient. A call for new definitions and risk assessment strategies, Part II. Circulation 2003;108:1772-1778.
27. Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient, Part III: Executive summary of the screening for heart attack prevention and education (SHAPE) task force report. Am J Cardiol 2006;98(suppl):2H-15H.
28. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874.
29. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
30. Fuster V, Moreno PR, Fayad ZA, et al. Atherothrombosis and high-risk plaque, Part I: Evolving concepts. J Am Coll Cardiol 2005;46:937-954.
31. Davies MJ, Woolf N, Rowles PM, et al. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J 1988;60:459-464.
32. Viles-Gonzalez JF, Fuster V, Badimon JJ. Links between inflammation and thrombogenicity in atherosclerosis. Curr Mol Med 2006;6:489-499.
33. Schwartz SM, Virmani R, Rosenfeld ME. The good smooth muscle cells in atherosclerosis. Curr Atheroscler Rep 2000;2:422-429.
34. Geng YJ, Libby P. Progression of atheroma: A struggle between death and procreation. Atherioscler Thromb Vasc Biol 2002;22: 1370-1380.
35. Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316-2325.
36. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006;47:C13-C18.
37. Fuster V, Fayad ZA, Moreno PR, et al. Atherothrombosis and high-risk plaque, Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol 2005;46:1209-1218.
38. Wilensky RL, Song HK, Ferrari VA. Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques. J Am Coll Cardiol 2006;47:C48-C56.
39. Davies JR, Rudd JHF, Weissberg PL, Narula J. Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol 2006;47:C57-C68.
40. Bax JJ, Beanlands RS, Klocke FJ, et al. Diagnostic and clinical perspectives of fusion imaging in cardiology: Is the total greater than the sum of its parts? Heart 2007;93:16-22.
41. Libby P. Act local, act global: Inflammation and the multiplicity of "vulnerable" coronary plaques. J Am Coll Cardiol 2005;45: 1600-1602.
42. DeMaria AN, Narula J, Mahmud E, Tsimikas S. Imaging vulnerable plaque by ultrasound. J Am Coll Cardiol 2006;47:C32-C39.
43. Stamper D, Weissman NJ, Brezinski M. Plaque characterization with optical coherence tomography. J Am Coll Cardiol 2006;47:C69-C79.
44. Caplan JD, Waxman S, Nesto RW, Muller JE. Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques. J Am Coll Cardiol 2006;47:C92-C96.
45. Casscells W, Hathorn B, David M, et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: Possible implications for plaque rupture and thrombosis. Lancet 1996;347: 1447-1451.
46. Schaar JA, van der Steen AFW, Mastik F, et al. Intravascular palpography for vulnerable plaque assessment. J Am Coll Cardiol 2006;47:C86-C91.
47. Strauss HW, Mari C, Patt BE, Ghazarossian V. Intravascular radiation detectors for the detection of vulnerable atheroma. J Am Coll Cardiol 2006;47:C97-C100.
48. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-1504.
49. Braunwald E. Epilogue: What do clinicians expect from imagers? J Am Coll Cardiol 2006;47:C101-C103.
50. Valgimigli M, Rodriguez-Granillo GA, Garcia-Garcia HM, et al. Distance from the ostium as an independent determinant of coronary plaque composition in vivo: An intravascular ultrasound study based radiofrequency data analysis in humans. Eur Heart J 2006;27:655-663.